Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Barinthus HPV-related cancer drug doesn't prove efficacy
Barinthus' high risk human papillomavirus-associated cervical cancer treatment is safe, but a phase 1 test failed to prove it actually works.
James Waldron
Apr 19, 2024 9:50am
Recursion, Canaan, Metsera and more—Chutes & Ladders
Apr 19, 2024 8:30am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Fierce Biotech Fundraising Tracker: Metsera, Asher Bio & more
Apr 18, 2024 4:55pm
Sponsored
Cognizant & Takeda Discuss Digital Transformation in Lifescience
Feb 12, 2024 8:00am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am